Agarwal Toughened Glass India IPO

Closed

Already have an account? Apply now

28th Nov 2024 – 02nd Dec 2024
05 Dec 2024
₹105 – ₹108
Lot size 1200 — ₹129600
63cr

Schedule of Agarwal Toughened Glass India

Issue open date 28 Nov 2024
Issue close date 02 Dec 2024
UPI mandate deadline 02 Dec 2024 (5 PM)
Allotment finalization 03 Dec 2024
Refund initiation 04 Dec 2024
Share credit 04 Dec 2024
Listing date 05 Dec 2024
Mandate end date 17 Dec 2024
Lock-in end date for anchor investors (50%) 02 Jan 2025
Lock-in end date for anchor investors (remaining) 03 Mar 2025

Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.

About Agarwal Toughened Glass India

Agarwal Toughened Glass India Limited, established on October 30, 2009, transitioned to a public limited company on March 6, 2023. Initially focused on building its manufacturing capacity, it began operations by trading glass and later specialized in toughened and value-added glass products like laminated and double-glazed glass. Serving industries such as construction and automotive, the ISO 9001:2015-certified and BIS-compliant company operates exclusively in India, managing client-specific production through an experienced sales team.


Financials of Agarwal Toughened Glass India


Issue size

Funds Raised in the IPO Amount
Overall ₹62.64 crores
Fresh Issue ₹62.64 crores

Utilisation of proceeds

Purpose INR crores (%)
Purchase machinery at the existing manufacturing unit 9.66 (15.43%)
Working capital requirements 25 (39.91%)
Repayment of certain Borrowing 6.00 (9.58%)

Strengths

  • Strong brand presence with high credibility
  • Experienced promoters & market adaptability​
  • Long-standing relationships with repeat customers
  • Focus on quality assurance with ISO 9001:2015 certification

Risks

  • Revenue concentration on a few key customers
  • Dependency on domestic sales limits market diversification.
  • Regulatory and compliance risks tied to BIS and quality standards​
  • Unsecured borrowings and director loans